Undergraduate study of economic sciences at the universities of Mainz and Würzburg, degree in business management (1985)
1985 - 1997 Pharmaceutical wholesaling, most recently Managing Director at PHOENIX Pharma Einkauf GmbH, Dreieich
1997 - 1999 Management Board member of GESKO eG, Gerlingen (purchasing cooperative)
Independent pharmaceuticals entrepreneur since 1999
Independent pharmaceuticals entrepreneur and Managing Shareholder of pharmarissano Arzneimittel GmbH since 2004
Doctorate in economic and social history from the University of Frankfurt am Main (2014)
Dr. Hommel is Chairman of the Nomination Committee, Chairman of the General Committee and Deputy Chairman of the Audit Committee of the Supervisory Board.
Dr. Hommel does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.
Dr. Barbara Ooms-Gnauck
Deputy Chairwoman of the Supervisory Board (appointed until 2023)
Born on 28 October 1957, Belgian citizen
Study of chemistry and ecototrophology at the University of Bonn, degree in ecototrophology (1983)
Study of jurisprudence of the University of Göttingen, First State Examination (2001)
Probationary Training Period at the District Court of Kassel, Second State Examination (2004)
Attorney (2004)
2005 - 2010 Attorney, partner at GKMP Rechtsanwälte Steuerberater Wirtschaftsprüfer
Shareholder in and attorney at Gnauck Rechtsanwälte GbR since 2010
Doctorate awarded by the University of Constance (2012)
Specialist lawyer for administration law (2016)
Dr. Ooms-Gnauck is a member of the Nomination and General committees of the Supervisory Board.
Dr. Ooms-Gnauck does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.
Uwe Andreas Krämer
(appointed until 2023)
Born on 27 October 1978, German citizen
Degree in business information technology from the Technical University of Darmstadt (2006)
2008 – 2014: Venture & growth capital investment professional focusing on software and internet technology, ViewPoint Capital, Frankfurt/Zürich
2016 – 2018 Managing Director & CFO/CCO of enterprise software company Fision AG, Zürich
Since 2014 growth capital investor focusing on cleantech, Zouk Capital, London
Since 2018 Vice President Finance & Operations of enterprise software company Scandit AG, Zürich
Mr. Krämer is a member of the Nomination Committee of the Supervisory Board.
Mr. Krämer does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.
Winfried Klar
(appointed until 2023)
Born on 10 October 1954, German citizen
Degree in business administration from the University of Münster (1979)
Auditor and tax consultant PwC Dusseldorf (1980-1990)
1991 - 1992 Head of Group development EVONIK (formerly RAG)
1993 - 2003 Managing Director, Management Board member, CFO at various companies
2004 - 2009: Managing Director and CFO of VESTOLIT GmbH & Co KG, Marl
2009 - 2013: Managing Director and CFO of MAUSER Holding GmbH, Brühl
2013 - 2019: management consulting in the Middle East, KMC Klar Management Consultancies, Dubai
Mr. Klar has been the Chairman of the Audit Committee of the Supervisory Board since 2016.
Mr. Klar does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.
Dr. Eberhard Kroth
(appointed until 2023)
Born on 15 June 1956, German citizen
Undergraduate studies and doctorate at the Technical University of Darmstadt (1985)
1986 - 1994 Company officer and Technical Director at Reis Robotics, Reis GmbH & Co KG
1994 - 2010 Managing Director at Reis Robotics, Reis GmbH & Co KG
2010 - 2016 Managing Director at Reis Group Holding GmbH
2015 - 2016 Managing Director & Chief Technical Officer (CTO) of KUKA Industries GmbH
Since 2017 Managing Shareholder of RoPro4.0 GmbH, automation technology
Dr. Kroth is a member of the Audit Committee.
Dr. Kroth does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.
Dr. Burkhard Wichert
(appointed until 2023)
Born 05 December 1961, German citizen
Place of residence: Bielefeld (North Rhine-Westphalia)
Member of the Supervisory Board since 2021
Studied pharmacy at the Westfälische Wilhelms University in Münster (1987)
Doctorate in pharmaceutical technology (1989)
1990 - 2001 various positions in research and development and production at ASTA Medica
2002 - 2016 various positions in operations including commercial and operational head of global contract manufacturing at Baxter Halle (Westphalia, Germany)
MBA from Buckinghamshire Chilterns University College (2007)
2016 - 2019 head of operations EMEA at Baxter Zurich
Since 2019 founder and managing director of pos pharma GmbH
Dr. Wichert does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.
